This company is a spinout from Takeda Pharmaceuticals and Kyoto University, focusing on the development of induced pluripotent stem cell (iPSC) technology-based regenerative medicine.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 2-26-1 Muraoka-Higashi, Fujisawa,kanagawa 251-8555,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Engineer jobs.
- HQ
- Fujisawa, Kanagawa
Orizuru Therapeutics, Inc. Questions
Orizuru Therapeutics, Inc.'s website is https://orizuru-therapeutics.com/en/
Orizuru Therapeutics, Inc.'s LinkedIn profile is https://jp.linkedin.com/company/orizuru-therapeutics-inc
Orizuru Therapeutics, Inc. has
18 employees.
View email and phone details for 18
employees at Orizuru Therapeutics, Inc..
Orizuru Therapeutics, Inc.'s industry is
Biotechnology Research
Orizuru Therapeutics, Inc.'s top competitors are
Peptigrowth Inc.,
Kenai Therapeutics,
Prism Biolab Co., Ltd.,
Sfg Sciences,
Thunder Biotech,
Chordia Therapeutics Inc,
Angitia Biopharmaceuticals,
サスメド株式会社(Susmed, Inc.),
Augustine Therapeutics,
Biolexis Therapeutics, Inc..
Orizuru Therapeutics, Inc.'s categories are Biotechnology Research
Orizuru Therapeutics, Inc.'s founding year is 2021
